Jones Financial Companies Lllp Boosts Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Jones Financial Companies Lllp lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 227.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 970 shares of the medical device company’s stock after buying an additional 674 shares during the quarter. Jones Financial Companies Lllp’s holdings in Cooper Companies were worth $89,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies during the 4th quarter valued at approximately $33,000. Brown Brothers Harriman & Co. increased its holdings in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares during the period. West Financial Advisors LLC bought a new stake in Cooper Companies during the 4th quarter worth approximately $49,000. UMB Bank n.a. increased its holdings in Cooper Companies by 22.5% during the 4th quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock worth $71,000 after acquiring an additional 142 shares during the period. Finally, Brooklyn Investment Group bought a new stake in Cooper Companies during the 3rd quarter worth approximately $86,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

COO has been the topic of a number of analyst reports. Citigroup decreased their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Morgan Stanley decreased their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Robert W. Baird decreased their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Wells Fargo & Company upped their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Finally, Stifel Nicolaus decreased their price target on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies has an average rating of “Moderate Buy” and an average price target of $111.89.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $81.22 on Monday. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The stock has a market capitalization of $16.24 billion, a price-to-earnings ratio of 41.65, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a fifty day moving average of $91.20 and a 200-day moving average of $98.93. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.